Back to company

OLANDER CLINICAL CONSULTING K/S: Financial statements 2019

CVR: 35860177

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,436,888 and a net result of DKK 1,407,595 compared with DKK 1,680,844 the year before. That is a decrease of 16.2% compared with the year before. Equity amounted to DKK 490,570. The solvency ratio was 60.7%.

Gross Profit
1,436,888 kr.
Profit/Loss
1,407,595 kr.
Equity
490,570 kr.
Total Assets
808,619 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.4 mio.1.4 mio.491 t.-
2018-1.7 mio.1.7 mio.700 t.-
2017-1.3 mio.1.3 mio.518 t.-
2016-1.5 mio.1.5 mio.699 t.-
2015-817 t.790 t.683 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

OLANDER CLINICAL CONSULTING K/S: The 2018 annual report is outJun 25, 2019

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2018. Gross profit came to DKK 1,714,996, and the net result was DKK 1,680,844.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.